Modulation of salt transport rate affects DNA synthesis in vivo in rat renal tubules  by Loffing, Johannes et al.
Kidney International, VoL 47 (1995), pp. 1615—1623
Modulation of salt transport rate affects DNA synthesis in vivo in
rat renal tubules
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Modulation of salt transport rate affects DNA synthesis in vivo in rat
renal tubules. In adult male Wistar rats we investigated whether cell
proliferation contributes to salt load-induced hypertrophy of distal tu-
bules. In one treatment group salt transport in the thick ascending limb
(TAL) was inhibited by furosemide (7.5 mg/l00 g body wt124 hr, via
osmotic minipump) and stimulated in the successive distal segments by
simultaneous high salt intake (F + Salt). Controls without furosemide
treatment had a standard salt intake. All animals received the thymidine
analog bromodeoxyuridine (BrdU) during 24 and 72 hours, respectively.
In cryostat sections of the perfusion-fixed kidneys DNA synthesis was
assessed by immunohistochemistxy for BrdU, and for endogenous prolif-
erating cellular nuclear antigen (PCNA). Incidence of BrdU- and PCNA-
labeled nuclei were quantified in proximal tubules, medullary TAL, and
cortical distal segments downstream the TAL. In control animals low
labeling indices were found in all investigated segments. After 24 and 72
hours of F + Salt, indices of labeled nuclei were markedly increased in
distal segments downstream the TAL, whereas they were significantly
reduced in TAL. In proximal tubules increased DNA synthesis rate was
apparent only after 72 hours. The data demonstrate that (1.) DNA
synthesis rate in nephron segments in viva varies in parallel with changes
of their salt transport activity; (2.) increased DNA synthesis, thus probably
cellular proliferation, is a component of the structural response of
nephron segments following increased salt transport activity.
Experimental studies after unilateral nephrectomy suggested
that the compensatory hypertrophy in the remnant kidney con-
sisted essentially in hypertrophy of the individual epithelial cells
[1], since no substantial increases in DNA synthesis and in the
expression of immediate early genes were observed. It was
concluded that cells undergoing hypertrophy may be arrested in
G0 phase and do not progress through the cell cycle [1]. In
contrast, proliferation has been described to occur in regenerative
hypertrophy after tubular damages and subtotal nephrectomy [2,
3]. However, other authors also demonstrated in the hypertro-
phied remnant kidney after unilateral nephrectomy increases in
early immediate gene expression and increases of mRNA for the
endogenous proliferating cell nuclear antigen (PCNA) [4]. PCNA
is a cofactor for DNA-polymerase a and plays an important role
in DNA replication during cellular proliferation [5].
In our present investigation we addressed the question of
whether the adaptive hypertrophy in distinct nephron segments of
non-injured kidneys following altered transport activity [reviewed
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in 6] comprises significant changes in DNA synthesis rate and
possibly cellular proliferation. To this aim we used a functionally
and structurally extensively-studied experimental model in which
high tubular salt load in distal tubules is produced by continuous
furosemide treatment and simultaneous high salt and fluid intake
[7, 8]. In previous studies with this model we had observed an
unusually high incidence of mitoses in the markedly hypertro-
phied distal tubular epithelia. We now assessed DNA synthesis in
structurally defined tubular segments by immunostaining of the
endogenous marker for DNA synthesis, PCNA, and of the
thymidine analog, bromodeoxyuridine (BrdU) [9], that was in-
fused to the rats during the whole experimental period. BrdU is
incorporated in replicating DNA and is found in all nuclei that
during the period of BrdU application replicated DNA. This
experimental procedure should reveal whether changes of DNA
synthesis rate and cell proliferation occur in vivo in non-injured
renal epithelial cells, and discriminate in which of the renal
tubular segments DNA synthesis was affected by the treatment.
In control animals we found a similar low rate of DNA
replication in all nephron segments. After 24 and 72 hours of the
experimental treatment we observed three different patterns of
modulation of DNA synthesis rate along the nephron: (1.) an
important early increase in DNA synthesis in the cortical seg-
ments downstream the TAL; (2.) a significant, though transient
decrease in DNA synthesis in the medullary TAL; and (3.) a
delayed increase in DNA synthesis in the proximal tubule. In all
three nephron segments a correlation between the workload of
the respective segments and their cellular proliferation rate can be
postulated.
Methods
Experimental design
The experiments were performed on 20 adult male Wistar rats
(BRL, Füllinsdorf, Switzerland) of 159 2 g (mean 5EM) body
weight. They were distributed into four groups of five animals
each. All animals were housed in metabolic cages starting two
days before the onset of the treatment until sacrifice. They had
free access to standard lab chow and drinking solutions. The
control animals (Control 24 and Control 72) received BrdU
continuously during 24 and 72 hours, respectively. They drank
only tap water, The other two groups (F + Salt 24 and F + Salt
72) received BrdU and furosemide during 24 and 72 hours,
respectively. These animals choose to drink large quantities of a
solution containing 0.8% NaCI and 0.1% KC1, offered ad libitum
besides tap water; thus, their salt intake was high (Table 1).
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Table 1. Fluid intake, urine flow rate and osmolality, and body and kidney weights
Tap
Water Salt solution Urine flow rate . .Urine osmolahty
mOsm/kg H20
Body weight Kidney weight
Group ml/24 h g
Control 24 17 1 nob 5 1 1663 76 162 1 1.62 0.05
F + Salt 24 16 4 61 18 71 8° 490 13' 142 1 1.71 0.05
Control 72° 19 1 no" 5 2 1616 145 172 4 1.81 0.01
F + Salt 72° 19 7 118 38 107 27C 480 35" 151 3" 1.90 0.12
Data are means SEM; 24 hr, N = 10 rats; 72 hr, N = 5 rats/group.
Fluid and urine data during 24 hours preceding sacrifice, not offered
P < 0.05 vs. corresponding control group
Application of the drugs
The drugs were applied via osmotic minipumps (model 2ML1
Aizet, Palo Alto, CA, USA), that were implanted between 9:15
a.m. and 10:45 a.m. subcutaneously in the neck region under light
anesthesia with methohexital (5 mg/100 g body wt i.p., Brietal®,
Lilly, Giessen, Germany). The pumps in Controls contained BrdU
(25 mg/mI; Calbiochem, La Jolla, CA, USA), dissolved in 0.9%
NaC1. In F + Salt rats the pumps contained BrdU and furosemide
(50 mg/mI; Dimazon® Hoechst, Unterschleissheim, Germany).
The pumps were primed for four hours prior implantation in 37°C
warm saline. The delivery rate of the pumps was 10 1il/hr. Thus,
the doses/24 hr/animal were —6 mg of BrdU (—3.75 mg/100 g),
and —12 mg of furosemide (—7.5 mg/100 g). The F + Salt animals
received a loading dose of furosemide (15 mg/100 g body wt i.p.)
simultaneously with the implantation of the pump.
Laboratory analyses
Body weight, fluid intake, urinary volume and osmolality were
measured daily. Blood samples for measurements of the hemat-
ocrit, blood pH and bicarbonate concentration in plasma were
taken from the capillary plexus in the tail of the anesthetized
animals immediately before sacrifice.
Fixation and tissue processing
All animals were sacrificed exactly 24 hours (Control 24 and
F + Salt 24) or 72 hours (Control 72 and F + Salt 72) after
implantation of the pumps. The animals were anesthetized with
Thiopental (Trapanal®, Byk Gulden, Konstanz, Germany), 10
mg/100 g body wt i.p., and the kidneys were fixed by intravascular
perfusion through the abdominal aorta as described previously
[10]. The fixative solution was composed of 0.1% glutardialde-
hyde, 2.5% paraformaldehyde and 0.05% picric acid in a 6:4
mixture of 0.1 M cacodylate buffer (pH 7.4, adjusted to 300 mOsm
with sucrose) and 10% hydroxyethyl starch in saline (HAES
steril°, Fresenius AG, Germany). The fixed kidneys were re-
moved, weighed and stored until further use at 4°C in 0.1 M
cacodylate buffer (pH 7.4, 300 mOsm) supplemented with 0.04%
NaN3.
From each left kidney four tissue blocks (of —5 X 3 mm side
lengths) extending from the renal capsule to the upper third of the
inner zone were embedded according to routine procedures in
epoxy resin. One gm-thick sections were cut with an ultra-
microtome (Reichert Jung, Vienna, Austria), stained with 1%
methylene blue and 1% azure II and studied with a light micro-
scope (Polyvar, Reichert Jung).
Table 2. Hematocrit, blood pH and bicarbonate concentration in
furosemide-treated and control animals at day of sacrifice
Group
Hematocrit
% pH
HC03
mEq/liter
Control 24 42 1 7.41 0.01 24.0 0.9
F + Salt 24 47 2° 7.52 0.01° 28.9 0.6°
Control 72 43 1 7.45 0.04 25.3 0.6
F + Salt 72 46 1° 7.50 0.02 29.9 1.3'
Data are mean SEM; N = 5 rats/group.
P < 0.05 vs. corresponding control group
Immunohistochemistiy
For immunohistochemistry we cut coronal slices across the
right kidneys, comprising the cortex, the outer medulla and part of
the inner medulla. The slices were frozen in liquid propane,
cooled with liquid nitrogen, and 5 j.m thick serial sections were
cut in a cryostat. Three consecutive sections were placed on one
chrome alum gelatin-coated slide for detection of BrdU, PCNA
and Vimentin, respectively. The latter was used in order to reveal
regenerating tubular cells [11].
For detection of BrdU we used a monoclonal antibody directed
against BrdU (Becton-Dickinson, San Jose, CA, USA), diluted
1:100 in PBS with 0.5% BSA (PBS-BSA). Because the antibody
recognizes incorporated BrdU in single-stranded DNA only,
DNA was denatured by treating the sections with 0.25 N NaOH at
25°C for 15 minutes prior immunostaining. The monoclonal
antibodies against PCNA (Dakopatts, Glostrup, DK) and against
Vimentin (clone V9, Boehringer Mannheim Biochemica) were
diluted 1:50 in PBS-BSA. The binding sites of primary antibodies
were visualized with a fluorescein isothiocyanate (FITC)-labeled
goat-anti-mouse-IgG (Dakopatts) diluted 1:40 in PBS-BSA. Cell
nuclei were stained with 4, 6-diamidino-2-phenylindole dihydro-
chloride (DAPI; Boehringer, Mannheim), 2 mg of which were
added per 1 ml of the working dilution of the secondary antibody.
After repeated rinsing in PBS the slides were mounted in DAKO-
glycergel (Dakopatts) containing 2.5% of 1,4-diazabicyclo [2.2.2]-
octane (DABCO; Sigma, St. Louis, MO, USA) as fading retar-
dant. The sections were studied by epifluorescence, using a filter
with a band width of 475 to 495 nm for FITC-labeled structures,
and with 330 to 380 nm for DAPI-stained nuclei.
Determination of the labeling index of cell nuclei
The labeling index for PCNA and BrdU (L1%c = antibody-
labeled nuclei per 1000 DAPI-stained nuclei) was assessed for
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Fig. 1. Bromodeoxyuridine (BrdU) -labeled cell nuclei in kidney cortex of rats after 72 hours of continuous BrdU application. (A) control rat; (B)rat after
72 hours of furosemide treatment, combined with high salt intake (F + Salt 72); in these rats nuclear labeling in distal convoluted tubules (D) is much
more frequent than in control rats on a standard salt intake. Arrowheads transition from thick ascending limb (T) to distal convoluted tubule. Other
abbreviations are: CN, connecting tubule; P, proximal tubule; G, glomerulus; cryostat sections; inimunofluorescence. Magnification (A) and (B) -360x.
Bar 50 rm.
each of the following segments: convoluted (PCT) and straight
(PST) parts of proximal tubules; medullary thick ascending limb
of Henle's loop (MTAL); distal convoluted tubule (DCT); con-
necting tubule (CNT); and cortical collecting duct (CCD).
The tubular segments were identified at a microscopic magni-
fication of 320x, using differential interference Contrast, and in
each field of view their profiles were outlined with a white pen on
a black board (microscope equipped with a drawing tube). Within
the tubular profiles the positions of all DAPI-stained nuclei, and
thereafter of the FITC-labeled nuclei, were marked. For each
analyzed segment in a given animal as many profiles were
screened until a sum of 1000 to 2500 DAPI-stained nuclei was
collected. Furthermore, in each of the Control 72 and F + Salt 72
animals we counted in cryostat sections the number of DAPI-
stained cell nuclei in at least 30 cross sectional profiles of DCT's.
Profiles were collected from one single section per tissue block.
This procedure excluded repeated analyzes of the same tubular
profiles in successive sections.
Statistics
The data are given as means SEM. In groups Control 24 and
F + Salt 24 five animals, and in the groups Control 72 and F +
Salt 72 four animals were evaluated morphologically, since in both
72 hours groups one animal had to be excluded because of poor
tissue fixation. The laboratory analyses were made in five animals!
group.
Statistical differences between group and segment means were
evaluated by analysis of variance (ANOVA) in conjunction with
the Student's 1-test and Scheffe test using standard computer
software. First, we made a one way ANOVA, analyzing the four
groups together, and second, we performed a two way ANOVA,
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Fig. 2. Proliferating cell nuclear antigen (PCNA) in the inner stripe of the outer medulla. (A) Control rat and (B) rat after 24 hours of furosemide treatment,
combined with high salt intake (F + Salt 24). Profiles of thick ascending limb with PCNA-positive nuclei are marked by asterisks. The rate of labeled
TAL profiles is much higher in the control rat than in the F + Salt 24 rat; Abbreviations are: C, collecting duct; VB, vascular bundle; cryostat sections;
immunofluorescence. Magnification (A) and (B) —360X. Bar 50 tm.
taking into account treatment and time. Differences were consid-
ered to be significant when P < 0.05.
Results
Physiological data
Body and kidney weights, fluid intake, urinary output and
osmolality are given in Table 1. Before treatment body weight was
159 2 g. During the first 24 hours after implantation of the
pumps the gain of body weight in Control rats was small but it
increased steadily during the following 48 hours. The F +
Salt-treated rats had a substantial loss of body weight during the
first 24 hours after implantation of the pump; during the following
48 hours they gained body weight at a similar rate as the controls,
but they did not recover the weight before the treatment. The
kidney weights of Control rats and F + Salt-treated rats were
similar.
After implantation of the minipumps Control animals had a
similar fluid intake as in the pre-experimental period. The F +
Salt-treated rats drank approximately the same amount of tap
water as the Controls but in addition consumed large quantities of
the salt solution; salt intake increased with duration of the
treatment. The F + Salt-treated rats had an important diuresis
starting approximately 10 minutes after injection of the loading
dose of furosemide. Their urine osmolality was about 480 mOsm
24, 48 and 72 hours after the beginning of the treatment.
The blood analyses (Table 2) of F + Salt-treated animals
revealed metabolic alkalosis, evident by the increased blood pH
and blood bicarbonate concentration. The hematocrits were sig-
nificantly higher in F + Salt-treated rats than in Controls.
Together with the loss of body weights, the data point to volume
depletion in F + Salt rats after 24 and still after 72 hours of
treatment.
Qualitative aspects of labeling with BrdU and PCNA
Treatment of the tissue sections with 0.25 N NaOH for 15
minutes yielded a strong labeling of a subset of nuclei with
anti-BrdU antibodies, without any staining of other tissue com-
ponents and without apparent damage of the tissue structure
(Figs. 1 and 3). Cells in the various phases of mitosis were
recognized with the anti-BrdU antibody due to the heavily
fluorescent chromosomes. In proximal segments as well as in
distal segments downstream the TAL mitotic cells were more
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Fig. 3. Consecutive sections through renal cortical labyrinth of a rat treated for 72 hours with flirosemide and high salt intake. (A) Immunostaining of
bromodeoxyuridine; (B) immunostaining of the intermediate filament Vimentin. Vimentin was detected in glomeruli (G), vessels and some cells in the
peritubular space. Vimentin expression was absent in epithelial cells. Abbreviations are: P, proximal tubules; D, distal tubules; clyostat sections;
immunofluorescence. Magnification (A) and (B) —360x. Bar 50 /sm.
Table 3. PCNA labeling index (%) in control and furosemide- and salt-treated (F +Salt) rats
Proximal tubules Distal tubules
PCT PST MTAL DCT CNT CCD
Group
Control 1.9 0.4 7.0 0.8 7.3 1.1 11.9 1.3 8.4 1.2 6.6 1.2F + Salt 24 1.4 0.4 3.6 1.2 0.3 o.la 60.3 + 154b 25.1 4.2a 27.0 55a
F + Salt 24/Control 0.74 0.51 0.04 5.07 2.99 4.09F + Salt 72 10.0 1.la 18.5 4.2a 7.4 3.9 38.0 10.7' 26.3 3.0 23.0 2.9aF + Salt 72/Control 5.26 2.64 1.01 3.19 3.13 3.48
Data are means SEM. Control, N = 9 rats; data of Control 24 and Control 72 were virtually identical and are pooled in the table; F + Salt 24, N
= 5 rats; F + Salt 72, N = 4 rats.
a P < 0.05 F + Salt vs. Control
Significantly different from values of all other distal tubules in this group
frequently seen in F + Salt-treated animals than in Controls (not played a wide range of intensities. Nuclear PCNA expression is
quantified). highest during the transition from Gi to S-phase of the cell cycle
With anti-PCNA antibodies nuclear immunofluorescence dis- [12]. In agreement with other investigators [5, 13] only nuclei that
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Table 4. BrdU labeling index (%o) in control and furosemide- and salt-treated (F + Salt) rats
ProximaI tubules Distal tubules
MTAL DCT CNT CCDPCT PST
Group
Control 24 26.4 8.2 34.2 6.8 18.8 1.9 16.8 2.6 13.2 3.5 13.0 7.1
F + Salt 24 14.4 1.6 19.2 3.1 2.8 Ø9 52.6 17.1 25.0 7.9 36.6 12.2
F + Salt/Control 0.55 0.56 0.15 3.13 1.89 2.81
Control 72 77.5 8.5 155.0 15.5 106.5 16.0 80.5 3.1 70.3 7.4 68.0 10.7
F + Salt 72 250.2 11.Y' 573.5 39.9k 30.5 7.T' 618.8 14.5a 379.0 45 296.7 12.1
F + Salt/Control 3.23 3.70 0.29 7.69 5.39 4.36
Data are means SEM. Control 24 and F + Salt 24, N = 5 rats/group; Control 72 and F + Salt 72, N 4 rats/group. The data for the MTAL, DCT,
CNT and CCD in the F + Salt 72 group are significantly (P < 0.05) different from each other.
ap < 0.05 F + Salt vs. Control
displayed heavy and/or granular staining pattern (Fig. 2) were
considered as being in the early S-phase and counted in the
quantitative evaluation.
Effects of treatment on PCNA and BrdU labeling index
Under control conditions a low incidence of labeled cells,
indicating DNA synthesis, was present in all analyzed segments
(Tables 3 and 4). In Control animals the PCNA-LI's of corre-
sponding segments were almost identical in animals sacrificed 24
and 72 hours after implantation of the minipumps. Therefore the
PCNA data of both control groups were pooled. The results
obtained with the PCNA method (Table 3) and with the BrdU
method (Table 4) were concordant.
In proximal tubules of F + Salt 24 rats the index of PCNA and
of BrdU labeled nuclei was slightly lower than in Controls. In F +
Salt 72 rats both LI's were markedly higher than in the corre-
sponding Controls (Tables 3 and 4).
In the distal segments downstream the TAL (DCT, CNT, CCD)
PCNA labeling after 24 and 72 hours of F + Salt treatment (Table
3) revealed highly significant increases in the rate of DNA
replication. The index of BrdU labeled nuclei (Table 4) was highly
and significantly increased in all three distal segments after 72
hours of F + Salt treatment, whereas the increase after 24 hours
of treatment showed a rather large variation among the animals.
In the MTAL of F + Salt 24 rats the LI for both PCNA and
BrdU unveiled a strikingly reduced rate of DNA synthesis. In F +
Salt 72 animals the PCNA labeling, thus the rate of cells, entering
the S-phase was again similar as in controls, whereas the BrdU
labeling index was still markedly lower than in corresponding
controls (Tables 3 and 4). This obviously reflects the delay due to
the foregoing period of inhibition of synthesis. There were no
discernible effects of F + Salt on PCNA expression or on
incorporation of BrdU in glomeruli, vessels and interstitium.
Histological observations
The structure of the kidneys was examined in 1 .tm thick
stained sections of epon embedded tissue. Tubular lesions, such as
denudation of tubular basement membrane, cellular degeneration
and apoptosis were not visible in the analyzed segments of F +
Salt-treated animals and Controls.
The epithelial structure of DCT, CNT and CCD of F + Salt 24
animals was similar to that in Controls. In F + Salt 72 rats the
epithelial lining of distal segments appeared to be higher than
after 24 hours, but clearly less hypertrophic than after treatment
with furosemide and high salt intake for six days, described
previously [7, 14].
In Control 72 animals the number of nuclei per cross sectional
profile of DCT's was 6.2 0.1, in F + Salt 72 animals it was 9.3
0.3 (mean SEM, N = 4 per group; P < 0.001).
Immunostaining for Vimentin
Vimentin expression in tubular epithelia is found in regenerat-
ing cells following cellular lesions and dedifferentiation [11,
15—17]. In Control animals and slightly more frequently in F +
Salt-treated animals binding of the antibody was seen in a few
epithelial cells of the straight proximal tubules. It was never
observed in convoluted parts of proximal tubules and in distal
segments, neither in untreated nor in F + Salt-treated animals
(Fig. 3). Anti-Vimentin antibodies stained glomerular cells, arte-
rial vessels, capillaries and interstitial cells in all groups.
Discussion
Various experimental maneuvers, which chronically increase
tubular workload in distal tubules provoke tubular hypertrophy
comprising an increase of basolateral cell membrane surface and
mitochondrial volume [7, 8, 14, 15, 18—23], of Na, K-ATPase
activity [24, 251 and of protein synthesis [26]. In the present study
we used the treatment protocol that combines specific inhibition
of salt reabsorption in the thick ascending limb of Henle's loop
(TAL) by furosemide with a high salt intake. It thus assures a
continuous high salt delivery to the distal segments successive to
the TAL, in spite of diuresis, and causes massive hypertrophy in
these segments within six days, as shown previously by others and
us [7, 8, 14]. In these former studies, plasma sodium and protein
concentration, hematocrit, gain of body weight and blood pressure
had been found to be similar in treated and in untreated rats after
six days, but treated animals revealed hypokaliemia and metabolic
alkalosis [27J. After cessation of the chronic furosemide applica-
tion, transport capacity in the loop of Henle was immediately
restored and not different from untreated controls, whereas the
capacity for sodium reabsorption and potassium secretion in the
successive distal tubules was dramatically increased [271. From
these and similar studies [7, 8, 14, 19] it was concluded that the
adaptive hypertrophy in the cortical distal tubules was caused by
the chronic increase in sodium uptake, independent of alterations
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of extracellular volume and aldosterone levels [27], since qualita-
tively and quantitatively similar changes developed with the same
treatment protocol also in adrenalectomized rats with mainte-
nance mineralocorticoid dosage [27], as well as in rats, given in
addition supraphysiological doses of antidiuretic hormone [14].
We now investigated earlier phases in the adaptive process and
demonstrate marked modulations in the DNA synthesis rate after
24 and 72 hours of the treatment. The modulation displayed a
striking segment specificity since in the two immediately succes-
sive nephron segments, in the TAL and the DCT, the DNA
synthesis rate changed in opposite directions: transient almost
complete cessation of DNA synthesis in the TAL, and markedly
increased DNA synthesis rate in the DCT and following segments.
Evaluation of DNA synthesis and cellular proliferation
In defined tubular segments of tissue sections we estimated
nuclear DNA synthesis by immunostaining of endogenous PCNA
and of exogeneously applied BrdU. While nuclear staining with
both, PCNA and BrdU, indicates sites of DNA synthesis the
meaning of each is slightly different. During the entire period of
its application BrdU is incorporated in all newly synthesized
DNA. Thus, the number of nuclei stained with anti-BrdU will
necessarily cumulate with duration of the BrdU application. BrdU
immunolabeling has been proven to be particularly useful to
detecting proliferation in tissues with low cellular proliferation
rate [28, 29]. Furthermore, prolonged application of BrdU avoids
possible bias related to circadian rhythms of cell division fre-
quency. In contrast, a strong nuclear signal with anti-PCNA
depicts only that population of cells that at the time of sacrifice
entered the S-phase of the cell cycle [12, 13, 29]. Thus, PCNA
staining may disclose transient decreases or increases of DNA
replication rate during the treatment period, that might be hidden
with the BrdU method.
Our data on DNA synthesis rate, assessed by the PCNA method
in proximal tubules of controls (0.2% in the convoluted part; 0.7%
in the straight part) agree well with PCNA data on the proximal
convoluted tubule of human kidney (0.22%; [30]) and with those,
obtained by single pulse labeling with [3H]-thymidine (0.5 1%) or
with BrdU (0.81%) [28].
Replication of nuclear DNA is mandatory for cellular prolifer-
ation and evidence of DNA synthesis is by most researchers
interpreted as evidence for cell proliferation [4, 5, 13, 28]. Yet,
there are no methods available to date, that in vivo could
unequivocally demonstrate to what extent DNA replication is
followed by complete cytokinesis, and thus, by an increase in cell
number, Flow cytometry revealed that during compensatory renal
growth after unilateral ncphrectomy the detected small increase
in DNA synthesis reflects cellular proliferation and not polyploidy
[31]. The greater nuclear numbers in the segment profiles with
increased DNA synthesis and the higher incidence of mitoses in
the hypertrophic segments, observed in the present and in previ-
ous studies [7, 14, 19], agree with these data and suggest that the
higher rate of DNA synthesis is followed at least by karyokinesis.
Any signs of epithelial damage, such as denudation of tubular
basement membrane, apoptosis and epithelial Vimentin expres-
sion, were lacking in distal segments. Thus, the observed increase
in DNA synthesis rate and in nuclear profiles in distal segments
with stimulated salt transport rates can be interpreted to represent
cellular proliferation.
Distal cortical segments downstream the TAL
From all distal segments of treated animals the DCT showed
the greatest increase in the rate of DNA synthesizing cells (Tables
3 and 4; Figs. 1 and 3). The PCNA data revealed that the steepest
increase occurred apparently during the first 24 hours of treat-
ment (Table 3). Also in the two other cortical distal segments, the
CNT and CCD, PCNA expression was increased, but less than in
the DCT and the values in both segments were similar after 24
and 72 hours. The cumulative index of BrdU labeled cells after 72
hours of treatment was significantly higher in the DCT than in the
CNT and CCD (Table 4). These observations corroborate the
functional distinction of the DCT from both successive segments.
Many studies in rats and rabbit [reviewed in 6, 32] had suggested
that in the DCT the high tubular salt load per se stimulates
transport activity, but that in the CNT and the CCD transport
capacity increases in response to elevation of plasma levels of
mineralocorticoid hormones, even without a high salt load [19—22,
25, 27]. In contrast to the former observations made after six days
of treatment [7, 14, 27], the rats after 24 and still after 72 hours of
treatment manifested substantial loss of body weight and in-
creased hematocrit, that both are signs of volume depletion. It is
conceivable that at this early stage the renin-angiotensin-aldo-
sterone system has been stimulated by volume depletion and
thereby additionally contributed to increased transport and the
observed changes. Apparently the functional and structural
changes occurring within these first 72 hours are not sufficient for
achieving full compensation of the initial salt and fluid loss,
starting as early as 10 minutes after injection of furosemide.
Clinical findings in patients with chronic use of loop diuretics,
but without dietary salt restriction suggest that under this condi-
tion a similar increase in the capacity for salt reabsorption, as
observed in our experimental model, might occur in the segments
beyond the TAL [33]. After cessation of the diuretic treatment the
time course and the biological mechanisms of the regression of
transport capacity to pre-treatment values might be different in
tubular segments with hyperplasia than in segments with hyper-
trophy alone, and this might have practical implications.
What might be the link between transport activity of the cells
and DNA synthesis? Various transport systems, among others the
Na/H transport, Na/K/2C1 transport and the Na, K-ATPase,
control intracellular free concentrations of H, Na, and Ca .
These ions are known to be determinants in the cell cycle
progression through the Gi phase, and transient changes in
intracellular ion concentrations might directly activate growth-
related immediate early genes [34] or interfere in the cascade of
growth factor-induced gene activation [35—38]. Short-term
changes of cell volume [39] and transient alterations of metabolic
parameters that are affected by the transport activity (ratio of
ATP to ADP/AMP) [40, 41] may also be potent signals for gene
expression and DNA synthesis. These observations, made essen-
tially in cell culture models, fit with our findings on increased
DNA synthesis rate in vivo under conditions of augmented
transport activity. However, our results contrast with those of
some [1, 37], but not all [4] in vivo studies on compensatory renal
hypertrophy. Further studies have to resolve the apparent contra-
dictions.
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Thick ascending limb of Henle's loop
In the thick ascending limb of Henle's loop the Na/K!2C1 co-
transport across the luminal membrane is essential for NaCI re-
absorption [42]. Furosemide specifically blocks the Na/K!
2Cl cotransport 1421 and seems to decrease, at least transiently,
the intracellular sodium concentration [36, 43] and to reduce the
Na-K-ATPase activity in this segment [24, 43], even in the
presence of high salt delivery to the segment. Inhibition of
Na/K!2Cl cotransport in human skin fibroblasts by furosemide or
bumetanide, or lack of this transport in mutant fibroblasts [36]
markedly reduced mitogen-induced DNA synthesis, possibly by
preventing cells from entry into S-phase [44].
Our data show that inhibition of the Na/K!2Cl cotransport in
the TAL of rats transiently almost abolishes DNA synthesis in this
segment. What mechanisms convey the raise of the blockade of
DNA synthesis in the TALcells, apparent in the PCNA data after
72 hours of continuing furosemide treatment, is not known so far.
Structural changes in the TAL after 24, 72 hours and even after six
days of continuous treatment were not been observed in our
studies [7, 14] and six days of treatment with furosemide under
identical conditions did not affect the transport capacity of the
segment [27]. Yet prolonged reduction of the transport activity by
TAL cells over several weeks, by means of dietary salt depletion
[45] or chronic low levels of antidiuretic hormone [46, 47] was
associated with significantly lower transport capacity and epithe-
hal volume of the TAL. These effects have been interpreted as
adaptive hypotrophy.
Proximal tubule
The experimental conditions affected DNA synthesis also in
proximal tubules. In both, the proximal convoluted and proximal
straight tubules of treated rats, DNA synthesis rate seemed to be
slightly slowed down after 24 hours, and significantly increased
after 72 hours. These changes may again correlate with the
workload of the segments. Following the initial volume depletion
immediately after onset of diuresis, glomerular filtration rate
(GFR) probably transiently decreases [43]. Since GFR largely
determines the workload of the proximal tubule, a decrease in
GFR implies also a decrease of proximal tubule workload. With
prolonged furosemide application GFR increases [48]: (1.) due to
inhibition by furosemide of the tubuloglomerular feedback [49],
and (2.) in association with the high solute and fluid intake of the
animals. Additionally, sodium reabsorption in the proximal tubule
and stimulation of DNA synthesis might be promoted by higher
angiotensin II levels [50].
Significant stimulation of the DNA synthesis rate in proximal
tubules of adult animals has been demonstrated after subtotal
nephrectomy [reviewed 37, 51, 52] and, in particular in the straight
part, in association with repair mechanisms after tubular lesions,
induced by various pathological conditions [15—17, 53]. Such
lesions would be well recognizable in microscopy of 1 sm sections.
Tubular cells in damaged areas often display signs of cellular
dedifferentiation, evident by immunostaining for Vimentin [11,
16, 17]. In our study we never observed tubular damages or
Vimentin expressing cells in the convoluted part of the proximal
tubule, nor in any of the distal segments (Fig. 3) of either group,
but a few such cells were seen in the straight part of proximal
tubules in all animals, with a slightly higher incidence of F +
Salt-treated animals. Thus, the higher rate of BrdU labeled cells,
the PST of treated animals and in controls might represent in part
a higher cellular turnover or regeneration than in other segments.
The straight part of the proximal tubule secretes many xenobiot-
ics, including furosemide, by its organic anion transport system
[54, 55] and might therefore be particularly susceptible for toxic
damages.
In conclusion, DNA synthesis rate along the nephron is mod-
ulated under high salt intake, combined with furosemide treat-
ment. Significant increases in DNA synthesis were found in those
distal segments with sustained increased salt transport activity.
Marked reduction of DNA synthesis was apparent in the TAL, the
segment, in which transport activity was inhibited by furosemide.
Thus, a direct correlation seemed to exist between the rate of
DNA replication and tubular workload.
The findings suggest that in vivo the transport activity of the
cells seems to be an important factor in regulating DNA synthesis.
Besides changes in morphology and in the expression of specific
proteins, modification of the rate of DNA synthesis appears to
represent a previously unrecognized component of the adaptive
response to altered transport functions.
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